NO20023135D0 - <gamma>-IFN v¶skedråpe aerosol og fremgangsmåte derav - Google Patents

<gamma>-IFN v¶skedråpe aerosol og fremgangsmåte derav

Info

Publication number
NO20023135D0
NO20023135D0 NO20023135A NO20023135A NO20023135D0 NO 20023135 D0 NO20023135 D0 NO 20023135D0 NO 20023135 A NO20023135 A NO 20023135A NO 20023135 A NO20023135 A NO 20023135A NO 20023135 D0 NO20023135 D0 NO 20023135D0
Authority
NO
Norway
Prior art keywords
gamma
ifn
aerosol
solution
aqueous
Prior art date
Application number
NO20023135A
Other languages
English (en)
Other versions
NO20023135L (no
Inventor
Peter Van Vlasselaer
Woodruff J Emlen
Original Assignee
Intermune Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intermune Pharmaceuticals Inc filed Critical Intermune Pharmaceuticals Inc
Publication of NO20023135D0 publication Critical patent/NO20023135D0/no
Publication of NO20023135L publication Critical patent/NO20023135L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0085—Inhalators using ultrasonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Colloid Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Liquid Crystal Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20023135A 1999-12-30 2002-06-27 <gamma>-IFN v¶skedråpeaerosol og fremgangsmåte for fremstilling av denne NO20023135L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17392699P 1999-12-30 1999-12-30
PCT/US2000/042831 WO2001049260A2 (en) 1999-12-30 2000-12-22 Y-ifn liquid-droplet aerosol and method

Publications (2)

Publication Number Publication Date
NO20023135D0 true NO20023135D0 (no) 2002-06-27
NO20023135L NO20023135L (no) 2002-08-23

Family

ID=22634096

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20023135A NO20023135L (no) 1999-12-30 2002-06-27 <gamma>-IFN v¶skedråpeaerosol og fremgangsmåte for fremstilling av denne

Country Status (18)

Country Link
US (1) US20010043906A1 (no)
EP (1) EP1286658B1 (no)
JP (1) JP2003519169A (no)
KR (1) KR20020072563A (no)
CN (1) CN1230197C (no)
AT (1) ATE319424T1 (no)
AU (1) AU4525801A (no)
BR (1) BR0016884A (no)
CA (1) CA2395803A1 (no)
CZ (1) CZ20022220A3 (no)
DE (1) DE60026618T2 (no)
HK (1) HK1052876B (no)
MX (1) MXPA02006518A (no)
NO (1) NO20023135L (no)
NZ (1) NZ519773A (no)
PL (1) PL356817A1 (no)
WO (1) WO2001049260A2 (no)
ZA (1) ZA200205167B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6883516B2 (en) * 2000-04-27 2005-04-26 Chrysalis Technologies Incorporated Method for generating an aerosol with a predetermined and/or substantially monodispersed particle size distribution
AUPR381601A0 (en) * 2001-03-19 2001-04-12 Monash University Method of treating respiratory conditions
US6964761B1 (en) * 2001-12-12 2005-11-15 New York University Method of treating idiopathic pulmonary fibrosis with aerosolized IFN-γ
DE10218328A1 (de) * 2002-03-05 2003-09-25 Humboldt Uni Zu Berlin Medizin Mittel zur präventiven Therapie nach akutem Schlaganfall
US20050232899A1 (en) * 2002-05-31 2005-10-20 Aradigm Corporation Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b
US6830744B2 (en) 2002-05-31 2004-12-14 Aradigm Corporation Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b
WO2004000266A1 (en) * 2002-06-20 2003-12-31 Yuriy Vasilievich Tyagotin Method for oral transmucosal delivery of interferon
US20040235308A1 (en) 2003-05-22 2004-11-25 Dainippon Screen Mfg. Co., Ltd. Substrate treatment method and sustrate treatment apparatus
US7244709B2 (en) * 2004-05-10 2007-07-17 Nastech Pharamecutical Company Inc. Compositions and methods for enhanced mucosal delivery of parathyroid hormone
CN103550757A (zh) * 2005-09-20 2014-02-05 纽约大学 用干扰素治疗肺病的方法
US8105571B2 (en) 2005-09-20 2012-01-31 New York University Method of treating pulmonary disease with interferons
CN101378774A (zh) * 2005-09-20 2009-03-04 纽约大学 用干扰素治疗肺病的方法
US20070065367A1 (en) * 2005-09-20 2007-03-22 Rany Condos Method of treating pulmonary disease with interferons
US8105572B2 (en) * 2007-05-18 2012-01-31 New York University Method of treating tuberculosis with interferons
WO2008143892A1 (en) * 2007-05-18 2008-11-27 New York University Method of treating tuberculosis with interferons
US8557485B2 (en) * 2008-12-11 2013-10-15 GM Global Technology Operations LLC Tungsten-containing hydrogen-storage materials for anodes of PEM fuel cells
JP2012193207A (ja) * 2012-07-13 2012-10-11 New York Univ インターフェロンを用いる肺疾患の処置方法
WO2016169571A1 (en) * 2015-04-20 2016-10-27 Ghaleb Haider Abbas Pharmaceutical product for treatment & prophylaxis of viral/ microbial infection
CN113491807B (zh) * 2020-04-03 2023-07-28 深圳麦克韦尔科技有限公司 一种气溶胶产生装置
CN116251174B (zh) * 2022-12-23 2023-09-29 北京三元基因药业股份有限公司 一种包含人干扰素α1b吸入溶液的药物组件

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE76311T1 (de) * 1986-08-19 1992-06-15 Genentech Inc Einrichtung und dispersion zum intrapulmonalen eingeben von polypeptidwuchsstoffen und zytokinen.
US5078997A (en) * 1988-07-13 1992-01-07 Cetus Corporation Pharmaceutical composition for interleukin-2 containing physiologically compatible stabilizers
US5780012A (en) * 1990-06-21 1998-07-14 Huland; Edith Method for reducing lung afflictions by inhalation of cytokine solutions
US5780014A (en) * 1995-04-14 1998-07-14 Inhale Therapeutic Systems Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin
US5763401A (en) * 1996-07-12 1998-06-09 Bayer Corporation Stabilized albumin-free recombinant factor VIII preparation having a low sugar content
US5855564A (en) * 1997-08-20 1999-01-05 Aradigm Corporation Aerosol extrusion mechanism

Also Published As

Publication number Publication date
KR20020072563A (ko) 2002-09-16
HK1052876B (zh) 2006-06-16
MXPA02006518A (es) 2004-07-30
DE60026618T2 (de) 2007-01-18
ATE319424T1 (de) 2006-03-15
BR0016884A (pt) 2002-10-01
CZ20022220A3 (cs) 2003-01-15
HK1052876A1 (en) 2003-10-03
CN1230197C (zh) 2005-12-07
NO20023135L (no) 2002-08-23
WO2001049260A2 (en) 2001-07-12
WO2001049260A3 (en) 2002-02-07
AU4525801A (en) 2001-07-16
JP2003519169A (ja) 2003-06-17
ZA200205167B (en) 2003-11-05
EP1286658B1 (en) 2006-03-08
EP1286658A2 (en) 2003-03-05
CN1434701A (zh) 2003-08-06
US20010043906A1 (en) 2001-11-22
CA2395803A1 (en) 2001-07-12
DE60026618D1 (de) 2006-05-04
NZ519773A (en) 2005-02-25
PL356817A1 (en) 2004-07-12

Similar Documents

Publication Publication Date Title
NO20023135D0 (no) &lt;gamma&gt;-IFN v¶skedråpe aerosol og fremgangsmåte derav
PT737066E (pt) Dispositivo transdermico contendo polivinilpirrolidona como potenciador de solubilidade
CA2329167A1 (en) Method and apparatus for enhancing flux rates of a fluid in a microporated biological tissue
DE69520492D1 (de) Flüssige arzneizubereitungen enthaltend schilddrüsenhormone
EP1138275A3 (en) Multiple solution dental irrigator
PL313389A1 (en) Tablet-type dosage form with many units containing a proton pump inhibitor
EP2522319A3 (en) Implantable drug delivery system
DE60231826D1 (de) Abgabevorrichtung für arzneimittel
GR3030369T3 (en) Transdermal drug delivery system
DE69907508D1 (de) Mikrobenbeständige und stabilisierte lösungen, die gamma-hydroxybuttersäuresalze zur behandlung von narkolepsie enthalten
DE59009462D1 (de) Implantierbare Vorrichtung zur dosierten Abgabe von Medikamenten in den menschlichen Körper.
ATE426424T1 (de) Vorrichtung zur nasalen oder oralen verabreichung eines medikamentes
NZ501950A (en) Medicinal compositions for application to mucosa
SG146638A1 (en) Pharmaceutical delivery system
DE60028367D1 (de) Oligonukleotide die eine antisense-sequenz enthalten die durch eine sekondärstruktur stabilisiert sind und pharmazeutische zusammensetzungen die sie enthalten
HRP960230B1 (en) Fluorophenyl substituted alkenyl carboxylic acid guanidines, processes for their preparation, their use as medicinal or diagnostic agent as well as medicaments containing them
ATE290858T1 (de) N-palmitoylethanolamid-enthaltende pharmazeutische zusammensetzungen und deren verwendung in der veterinärmedizin
BR9612287A (pt) Emprego de inibidores de troca de na+ /h+ (nhe) celular para a preparação de um medicamento para estimular a respiração
DE69527713D1 (de) Verbindunngen und zusammensetzungen zur verabreichung via inhalation und insufflierung
TW200509985A (en) Drug delivery system for sub-Tenon administration of fine particles
IL112435A0 (en) A pharmaceutical composition containing an acid active substance and processes for the preparation thereof
Bartelink " Virgins of God". The Making of Ascetism in Late Antiquity
TH55261B (th) การใช้ไบโอเจนิคอีสโตรเจนซัลฟาเมทในการรักษาการทดแทนฮอร์โมน
UA36073A (uk) Спосіб лікування невиношування вагітності
MX9705185A (es) Particula de resina, material medico y preparacion farmaceutica que contiene dicha particula de resina.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application